PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
2016 · Journal of Thoracic Oncology · 1,237 citations
https://doi.org/10.1016/j.jtho.2016.11.2228
J
James Ranger‐Moore
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
6.0K
Citations
33
h-index
67
i10-index
James Ranger‐Moore is an academic researcher from McKesson (United States). The author has contributed to research in topics: Nonmelanoma Skin Cancer Studies & Cutaneous Melanoma Detection and Management & Skin Protection and Aging. The author has an h-index of 33, co-authored 88 publications.
Papers by this author
worksHepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
2009 · Drug Metabolism and Disposition · 342 citations
https://doi.org/10.1124/dmd.109.027466
Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation
2018 · The American Journal of Surgical Pathology · 43 citations
https://doi.org/10.1097/pas.0000000000001072
Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine
2024 · Archives of Pathology & Laboratory Medicine · 10 citations
https://doi.org/10.5858/arpa.2023-0149-oa
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat